Nettet3 timer siden · Moderate chronic active ulcerative colitis in a biopsy specimen. Credit: CoRus13 / commons.wikimedia.org. The US Food and Drug Administration (FDA) has rejected Eli Lilly’s biologic licence application (BLA) for the ulcerative colitis (UC) drug mirikizumab over manufacturing concerns. The regulator has issued a complete … NettetThe FDA rejects Eli Lilly's (LLY) regulatory filing seeking approval for mirikizumab to treat ulcerative colitis indication, citing issues related to the drug's proposed manufacturing.
Lilly
Nettet21 timer siden · US regulators declined to approve Eli Lilly’s ulcerative colitis drug mirikizumab, the company said, citing manufacturing issues. Mirikizumab is an antibody that targets IL-23, and Lilly has ... Nettet13. mar. 2024 · Eli Lilly and Company's experimental intravenous drug donanemab could slow the cognitive decline of patients with Alzheimer's disease, according to early clinical trial results, published in The ... kids christmas mugs by the case
FDA rebuffs Eli Lilly
NettetAccording to Pfizer CEO Albert Bourla, an oral weight-loss drug would " [unlock] the market," which he estimated could be worth as much as $90 billion in the future. … Nettet11. jan. 2024 · Eli Lilly said on Monday a trial of its experimental Alzheimer’s drug donanemab showed it slowed by about a third the rate of decline in a combined measure of cognition and function in early ... Nettet14. apr. 2024 · Lilly remains bullish on the drug’s prospects, having previously highlighted it as one of the four new drugs set to launch this year that will continue the company’s growth trajectory. Still, one of the other drugs that Lilly was banking on, the Alzheimer’s drug donanemab, did not receive accelerated-approval from the FDA in late January. kids christmas movies on hbo